Expression of p63 in anaplastic large cell lymphoma but not in classical Hodgkin's lymphoma
- PMID: 18620733
- PMCID: PMC2744879
- DOI: 10.1016/j.humpath.2008.02.016
Expression of p63 in anaplastic large cell lymphoma but not in classical Hodgkin's lymphoma
Abstract
Immunohistochemical determination of p63 protein is frequently used in the pathologic diagnosis of nonhematological solid tumors. In malignant hematological disease, p63 expression has been reported in 22% of follicular lymphoma, about 35% of diffuse large B-cell lymphoma, 23% of chronic lymphocytic leukemia, and in some cases of blast crisis of chronic myelogenous leukemia. Anaplastic large cell lymphoma is a rare disease that accounts for less than 5% of all cases of non-Hodgkin's lymphoma. There is little information concerning p63 expression in this specific type of lymphoma. In some cases, the morphological and phenotypic features between anaplastic large cell lymphoma and classical Hodgkin's lymphoma are similar, making this differential diagnosis challenging. We studied p63 expression using a tissue microarray approach in 154 cases of anaplastic large cell lymphoma, including 38% anaplastic large cell kinase positive and 62% anaplastic large cell kinase negative, and 58 Hodgkin's lymphoma cases. Sixty-eight cases of anaplastic large cell lymphoma (44%) showed p63 nuclear positivity (41% of anaplastic large cell kinase positive and 47% of anaplastic large cell kinase negative). Of 130 cases of systemic-anaplastic large cell lymphoma, 42% showed p63 positivity. The neoplastic cells expressed p63 in 38% of the cases of CD45-negative/anaplastic large cell kinase-negative null cell-type anaplastic large cell lymphoma, a subgroup that offers the most difficulties in the differential diagnosis with classical Hodgkin's lymphoma. In contrast, none of the cases of classical Hodgkin's lymphoma demonstrated any p63 expression. These results demonstrate that p63 protein expression is frequently expressed in a subset of anaplastic large cell lymphoma cases and may be used as a potential tool in the differential diagnosis between anaplastic large cell lymphoma and classical Hodgkin's lymphoma.
Figures


Similar articles
-
Leucocyte-specific protein (LSP1) in malignant lymphoma and Hodgkin's disease.Br J Haematol. 2003 Feb;120(4):671-8. doi: 10.1046/j.1365-2141.2003.04137.x. Br J Haematol. 2003. PMID: 12588355
-
Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients.Am J Surg Pathol. 1999 Oct;23(10):1184-200. doi: 10.1097/00000478-199910000-00003. Am J Surg Pathol. 1999. PMID: 10524519
-
Clusterin expression in malignant lymphomas: a survey of 266 cases.Mod Pathol. 2002 Nov;15(11):1221-6. doi: 10.1097/01.MP.0000036386.87517.AA. Mod Pathol. 2002. PMID: 12429802
-
PAX-5 Positivity in Anaplastic Lymphoma Kinase-Negative Anaplastic Large Cell Lymphoma: A Case Report and Review of Literature.Int J Surg Pathol. 2017 Jun;25(4):333-338. doi: 10.1177/1066896916683447. Epub 2016 Dec 26. Int J Surg Pathol. 2017. PMID: 28013563 Review.
-
Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas.Leukemia. 2000 Sep;14(9):1533-59. doi: 10.1038/sj.leu.2401878. Leukemia. 2000. PMID: 10994999 Review.
Cited by
-
Burkitt lymphoma in Brazil is characterized by geographically distinct clinicopathologic features.Am J Clin Pathol. 2008 Dec;130(6):946-56. doi: 10.1309/AJCP64YOHAWLUMPK. Am J Clin Pathol. 2008. PMID: 19019773 Free PMC article.
-
Expression of p63 protein in anaplastic large cell lymphoma: implications for genetic subtyping.Hum Pathol. 2017 Jun;64:19-27. doi: 10.1016/j.humpath.2017.01.003. Epub 2017 Jan 30. Hum Pathol. 2017. PMID: 28153507 Free PMC article.
-
Proteomic analysis reveals key differences between squamous cell carcinomas and adenocarcinomas across multiple tissues.Nat Commun. 2022 Jul 18;13(1):4167. doi: 10.1038/s41467-022-31719-0. Nat Commun. 2022. PMID: 35851595 Free PMC article.
-
Analysis of human T-cell lymphotropic virus in CD25+ anaplastic large cell lymphoma in children.Am J Clin Pathol. 2009 Jul;132(1):28-33. doi: 10.1309/AJCP6Q7QMUVGMVMF. Am J Clin Pathol. 2009. PMID: 19864230 Free PMC article.
-
Comparative pathologic analysis of mediastinal B-cell lymphomas: selective expression of p63 but no GATA3 optimally differentiates primary mediastinal large B-cell lymphoma from classic Hodgkin lymphoma.Diagn Pathol. 2019 Dec 12;14(1):133. doi: 10.1186/s13000-019-0918-x. Diagn Pathol. 2019. PMID: 31831043 Free PMC article.
References
-
- Flores ER. The roles of p63 in cancer. Cell Cycle. 2007;6:300–4. - PubMed
-
- Hedvat CV, Teruya-Feldstein J, Puig P, et al. Expression of p63 in diffuse large B-cell lymphoma. Appl Immunohistochem Mol Morphol. 2005;13:237–42. - PubMed
-
- Di Como CJ, Urist MJ, Babayan I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res. 2002;8:494–501. - PubMed
-
- Nylander K, Vojtesek B, Nenutil R, et al. Differential expression of p63 isoforms in normal tissues and neoplastic cells. J Pathol. 2002;198:417–27. - PubMed
-
- Yamaguchi H, Inokuchi K, Tarusawa M, et al. Mutation of P51A/TAP63 g gene is associated with blastic crisis in chronic myeloid leukemia. Exp Hematol. 2000;28:76.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous